First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies
NovalGen Ltd.
NovalGen Ltd.
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Milton S. Hershey Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)